NCT03214198View on ClinicalTrials.gov

"Special Drug Use Surveillance of Vonoprazan for Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use"

CompletedOBSERVATIONAL
Enrollment

1,304

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
A History of Gastric or Duodenal Ulcers
Interventions
DRUG

Vonoprazan

Vonoprazan tablets

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03214198 - "Special Drug Use Surveillance of Vonoprazan for Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use" | Biotech Hunter | Biotech Hunter